7.89
0.28 (3.68%)
| 前收盘价格 | 7.61 |
| 收盘价格 | 8.14 |
| 成交量 | 11,234 |
| 平均成交量 (3个月) | 41,951 |
| 市值 | 109,094,240 |
| 市盈率 (P/E TTM) | 17.53 |
| 预期市盈率 (P/E Forward) | 22.88 |
| 价格/销量 (P/S) | 1.91 |
| 股市价格/股市净资产 (P/B) | 20.23 |
| 52周波幅 | |
| 利润日期 | 16 Jul 2025 - 21 Jul 2025 |
| 营业毛利率 | 10.97% |
| 营业利益率 (TTM) | 26.40% |
| 稀释每股收益 (EPS TTM) | 0.450 |
| 季度收入增长率 (YOY) | 41.80% |
| 总债务/股东权益 (D/E MRQ) | 117.70% |
| 流动比率 (MRQ) | 0.990 |
| 营业现金流 (OCF TTM) | -1.30 M |
| 杠杆自由现金流 (LFCF TTM) | -3.45 M |
| 资产报酬率 (ROA TTM) | 14.64% |
| 股东权益报酬率 (ROE TTM) | 376.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Champions Oncology, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.63 |
|
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 25.85% |
| 机构持股比例 | 47.79% |
| 52周波幅 | ||
| 中 | 12.00 (52.09%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Craig-Hallum | 12 Mar 2025 | 12.00 (52.09%) | 购买 | 9.55 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合